FDA — authorised 22 June 1998
- Application: NDA021024
- Marketing authorisation holder: SANOFI AVENTIS US
- Local brand name: PRIFTIN
- Indication: TABLET — ORAL
- Status: approved
🇺🇸 isoniazid and rifapentine in United States
FDA authorised isoniazid and rifapentine on 22 June 1998
Marketing authorisation
Other Infectious disease approved in United States
Frequently asked questions
Is isoniazid and rifapentine approved in United States?
Yes. FDA authorised it on 22 June 1998.
Who is the marketing authorisation holder for isoniazid and rifapentine in United States?
SANOFI AVENTIS US holds the US marketing authorisation.